Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 100,000 shares at $40.00 ($4.0M) on 2019-01-09, disclosed to the SEC on 2019-01-11.
Open-market sale of $4.0M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 25,000 | $1.0M | 25.0% |
| 2 | $40.00 | 75,000 | $3.0M | 75.0% |
| Total | $40.00 avg | 100,000 | $4.0M | 100% |
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |